Abrdn Healthcare Investors Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Abrdn Healthcare Investors.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Capital Markets earnings growth | 15.6% |
| Revenue growth rate | n/a |
| Future return on equity | n/a |
| Analyst coverage | None |
| Last updated | n/a |
Recent future growth updates
No updates
Recent updates
HQH: Healthcare Fund With 11% Income And A High Discount
Mar 03HQH: Disappointing Track Record
Feb 04HQH: I Am Getting A 9.5% Yield On My Last Buy
Dec 19HQH: New Name But Same Risky Bets On Biotech
Nov 14HQH: Deep Discount Presents An Opportunity
Jul 03Tekla Healthcare Investors raises dividend by 7.7% to $0.42
Feb 15HQH: 50 Big-Yield Healthcare Stocks, These 3 Worth Considering
Dec 24Equity CEFs: What's Going On With Tekla's HQH And HQL?
Dec 08Tekla Healthcare Investors declines quarterly dividend by -2.5% to $0.39/share
Nov 16HQH: A Dividend Paymaster That Fails To Register Price Growth
Oct 20Tekla Healthcare Investors goes ex-dividend tomorrow
Aug 24Tekla Healthcare: 10% Yielding CEF Trading Below NAV
Jul 17Tekla Healthcare Investors: A Dividend Paymaster That Can Compensate For Poor Price Performance
Mar 30Tekla Healthcare Investors: Understanding The Mechanics Of Its 8.5% Yield
Jan 16Technical Update On HQH: Presenting An Opportunity
Oct 06HQH: Higher Valuation, But Still Appealing
Jul 31Where Fundamentals Meet Technicals: HQH (Revisited) - Yield 7.74%
Jul 08Evaluating CEFs: HQH Provides A Well-Covered Distribution In A Hot Sector
Jun 27HQH: An Overweight Biotech Fund, Paying 8%+ Distribution
Jan 14Tekla Healthcare Investors declares $0.05 special dividend
Dec 21Tekla Healthcare Investors declares $0.48 dividend
Nov 16HQH: Deep Discount Leads To High Yield
Nov 09In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Abrdn Healthcare Investors has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 9/30/2023 | 10 | 56 | N/A | N/A | N/A |
| 6/30/2023 | 10 | 30 | N/A | N/A | N/A |
| 3/31/2023 | 10 | 4 | N/A | N/A | N/A |
| 12/31/2022 | 9 | -95 | N/A | N/A | N/A |
| 9/30/2022 | 8 | -194 | N/A | N/A | N/A |
| 6/30/2022 | 8 | -121 | N/A | N/A | N/A |
| 3/31/2022 | 7 | -48 | N/A | N/A | N/A |
| 12/31/2021 | 7 | 53 | N/A | N/A | N/A |
| 9/30/2021 | 6 | 155 | N/A | N/A | N/A |
| 6/30/2021 | 7 | 218 | N/A | N/A | N/A |
| 3/31/2021 | 7 | 282 | N/A | N/A | N/A |
| 12/31/2020 | 8 | 261 | N/A | N/A | N/A |
| 9/30/2020 | 9 | 241 | N/A | N/A | N/A |
| 6/30/2020 | 9 | 114 | N/A | N/A | N/A |
| 3/31/2020 | 9 | -13 | N/A | N/A | N/A |
| 12/31/2019 | 8 | -79 | N/A | N/A | N/A |
| 9/30/2019 | 8 | -145 | N/A | N/A | N/A |
| 6/30/2019 | 8 | -47 | N/A | N/A | N/A |
| 3/31/2019 | 7 | 50 | N/A | N/A | N/A |
| 12/31/2018 | 7 | 60 | N/A | N/A | N/A |
| 9/30/2018 | 7 | 69 | N/A | N/A | N/A |
| 6/30/2018 | 6 | 45 | N/A | N/A | N/A |
| 3/31/2018 | 6 | 20 | N/A | N/A | N/A |
| 12/31/2017 | 6 | 71 | N/A | N/A | N/A |
| 9/30/2017 | 6 | 121 | N/A | N/A | N/A |
| 6/30/2017 | 5 | 110 | N/A | N/A | N/A |
| 3/31/2017 | 5 | 98 | N/A | N/A | N/A |
| 12/31/2016 | 5 | 21 | N/A | N/A | N/A |
| 9/30/2016 | 5 | -56 | N/A | N/A | N/A |
| 6/30/2016 | 5 | -142 | N/A | N/A | N/A |
| 3/31/2016 | 5 | -227 | N/A | N/A | N/A |
| 12/31/2015 | 5 | -66 | N/A | N/A | N/A |
| 9/30/2015 | 4 | 96 | N/A | N/A | N/A |
| 6/30/2015 | 4 | 215 | N/A | N/A | N/A |
| 3/31/2015 | 3 | 334 | N/A | -65 | N/A |
| 12/31/2014 | 2 | 278 | N/A | -103 | N/A |
| 9/30/2014 | 2 | 222 | N/A | -141 | N/A |
| 6/30/2014 | 2 | 224 | N/A | -58 | N/A |
| 3/31/2014 | 2 | 227 | N/A | 25 | N/A |
| 12/31/2013 | 2 | 214 | N/A | 22 | N/A |
| 9/30/2013 | 2 | 200 | N/A | 20 | N/A |
| 6/30/2013 | 3 | 161 | N/A | 19 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if HQH's forecast earnings growth is above the savings rate (2.4%).
Earnings vs Market: Insufficient data to determine if HQH's earnings are forecast to grow faster than the US market
High Growth Earnings: Insufficient data to determine if HQH's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if HQH's revenue is forecast to grow faster than the US market.
High Growth Revenue: Insufficient data to determine if HQH's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if HQH's Return on Equity is forecast to be high in 3 years time